Pfizer gets Acceptable for $43-billion Seagen bargain
Pfizer (PFE.N) said on Tuesday it hopes to finalize its $43 billion negotiation to purchase disease drugmaker Seagen (SGEN.O)
Pfizer (PFE.N) said on Tuesday it hopes to finalize its $43 billion negotiation to purchase disease drugmaker Seagen (SGEN.O)
We, at Middle East Headlines, offer you the best and genuine content, which can be trusted blindly. We have a passion for quality, which makes our users happy. We truly think that the power of communication and interaction elevate experiences, simplify communications, and inspire & engage users all over the world.